Aytu BioPharma Inc — Cash Flow (NASDAQ:AYTU) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 26 M28.8 M5.1 M1.39 M1.94 M 3.28 M Cash from investing activities 2.78 M3.25 M117 K329 K2.56 M 2.05 M Cash from financing activities 30.31 M1.53 M8.87 M1.26 M15.44 M 17.56 M Free cash flow 26 M28.8 M5.1 M1.39 M-1.29 M 3.26 M

ニュース

Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript

Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates

アイトゥ・バイオファーマ2026年第2四半期決算：収益減少、株価下落

Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls

New Strong Sell Stocks for February 2nd

Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript

Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20

Aytu launches EXXUA, first selective 5-HT1A agonist for depression

アイトゥ・バイオファーマ株、うつ病治療薬EXXUAの商業発売後に上昇

Aytu BioPharma stock rises after commercial launch of depression drug EXXUA

アイトゥ・バイオファーマ、うつ病治療薬EXXUAを米国市場で発売

Aytu BioPharma launches depression drug EXXUA in U.S. market